Oxomemazine/guaifenesin

Oxomemazine/guaifenesin

Combination of
Oxomemazine	H1 receptor antagonist (antihistamine)
Guaifenesin	expectorant
Clinical data
Trade names	Toplexil and others
Routes of administration	Oral
ATC code	none
Identifiers
CAS Number	153445-20-6

Oxomemazine/guaifenesin is a sedative antihistamine plus expectorant.^[1][2] It is a combination of oxomemazine and guaifenesin.

It is sold under a variety of brand names including Toplexil by Aventis. It is sold over the counter in France, Morocco, Egypt, Algeria, South Korea and the UAE^{[citation needed]}. The oxomemazine ingredient (antihistamine) is not approved by the U.S. Food and Drug Administration (FDA), either for over the counter or prescription use. It is sold in France as cough syrup. French travelers also use it as a sleeping aid for long flights.^{[citation needed]}

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This page was last edited on 20 October 2022, at 22:35